TELA Bio Inc
TELA
Get informed when a big investor buys or sells
+ FollowMarket Cap$38.92M
Close$
$2.93
332.7% upside
Current Fair Value
332.7% upsideUndervalued by 332.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $38.92 Million |
|---|---|
| Enterprise Value | $55.24 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 1.34 |
| Outstanding Shares | 57,256,518 |
Return
| Return on Equity | 766.01% |
|---|---|
| Return on Assets | -57.00% |
| Return on Invested Capital | -64.22% |
Valuation & Multiples
| P/E Ratio | -1.1 |
|---|---|
| PEG | -12.29 |
| Price to Sales | 0.68 |
| Price to Book Ratio | -0.68 |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | -1.65 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -10.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$20.01 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$20.51 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 750,0000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 46.94%▼ 11.81% |
|---|---|
| Total Invested | $16.71M▼ 48.58% |
| Investors Holding | 36▼ 6.00% |
ESG Score
No data